Home  |  Slider   |  Media   |  After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: Sources

After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: Sources

Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their Covid-19 jabs in India, the Serum Institute of India (SII) has also sought protection against liabilities, sources said on Thursday.India News | Latest News Headlines & Live Updates from India – Times of India

The post After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: Sources appeared first on Planotech Media House.

WRITTEN BY: